[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "invasive breast cancer",
            "ER-negative breast cancer",
            "PR-negative breast cancer",
            "HER2-negative breast cancer",
            "triple negative breast cancer",
            "Triple-Negative Breast Cancer",
            "TNBC",
            "Breast cancer",
            "Breast malignancy",
            "breast malignancies",
            "metastatic breast cancer",
            "Metastatic TNBC",
            "Metastatic Triple-Negative Breast Cancer",
            "Metastatic Triple Negative Breast Cancer",
            "advanced breast cancer",
            "solid tumor",
            "late stage breast cancer/late-stage breast cancer"
        ],
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Phoenix Molecular Designs",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Signed informed consent"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Age \u2265 18 years"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "ECOG Performance Status \u2264 2"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "[Part 1 - Dose Escalation] Histologically or cytologically diagnosed metastatic breast cancer that has progressed on or after standard of care therapy and for which no standard of care therapy is available that would confer clinical benefit"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "[Part 2 - Dose Expansion] Histologically or cytologically diagnosed metastatic triple-negative breast cancer with <1% expression of ER and PR and negative for HER2 (either 0 or 1+ by IHC or IHC 2+ and fluorescence in situ hybridization (FISH) negative) from the time of initial diagnosis that has progressed on or after standard of care therapy and for which no standard of care therapy is available that would confer clinical benefit"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "[Part 1 - Dose Escalation] Evaluable or measurable disease by RECISTv1.1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "[Part 2 - Dose Expansion] Measurable disease by RECISTv1.1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Adequate laboratory parameters including:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Absolute Neutrophil Count (ANC) \u2265 1500/mm^3"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Platelets \u2265 100,000/mm^3"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "AST/SGOT \u2264 2.5 x ULN (\u2264 5 x ULN if known liver involvement)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "ALT/SGPT \u2264 2.5 x ULN (\u2264 5 x ULN if known liver involvement)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Total bilirubin \u2264 1.5 x ULN (unless diagnosis of Gilbert's syndrome in which case < 3.0 times ULN)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Serum creatinine \u2264 1.5 x ULN or estimated GFR \u2265 60 mL/min"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "If residual treatment related toxicity from prior therapy:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Treatment related toxicity resolved to at least Grade 1 (alopecia excepted), or"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "Treatment related toxicity resolved to at least Grade 2 with prior approval of the Medical Monitor"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "Available archival or fresh tumor tissue (Formalin-fixed paraffin-embedded [FFPE])"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "[Females] The patient must be postmenopausal, surgically sterile, or agree to use adequate contraception (adequate as determined by the PI - may include abstinence) throughout the study and for a least 30 days following the last dose of PMD-026"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "[Males] The patient must be surgically sterile or must agree to use adequate contraception (adequate as determined by the PI - may include abstinence) throughout the study and for at least 30 days following the last dose of PMD-026"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 20,
                    "description": "[Males] The patient must agree to refrain from donating sperm throughout the study and for at least 30 days following the last dose of PMD-026"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 21,
                    "description": "[Females] If of childbearing potential, the patient must have a negative serum pregnancy test"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "\u2264 14 days from prior chemotherapy, biological or investigational therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Use of any medications known to result in a prolongation of the QT/QTc interval"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Use of any medication that is a strong inducer or substrate of cytochrome P450 3A"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Use of any medications that is a substrate of BCRP"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Use of any medication that is a substrate of MATE2K"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "\u2264 28 days from prior irradiation (including therapeutic radioisotopes such as strontium 89)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "\u2264 7 days from limited field irradiation for palliation"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "\u2264 28 days from major surgical procedures"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "\u2264 7 days from minor surgical procedures (no waiting period required following central catheter placement)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "Central nervous system metastases, unless appropriately treated and neurologically stable for \u2265 28 days"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 32,
                    "description": "Known history of leptomeningeal metastases"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 33,
                    "description": "Uncontrolled bacterial, viral, or fungal infection (s) requiring systemic therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 34,
                    "description": "Pregnant or currently breast-feeding"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Known Hepatitis B or Hepatitis C infection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 36,
                    "description": "Known HIV-positive with CD4+ cell counts < 350 cells/uL"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 37,
                    "description": "Known HIV-positive with a history of an AIDS-defining opportunistic infection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 38,
                    "description": "History of clinically significant cardiovascular abnormalities including:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 39,
                    "description": "Congestive heart failure (NYHA classification \u2265 3 in within 6 months of first dose of PMD-026"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 40,
                    "description": "Unstable angina pectoris"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 41,
                    "description": "Myocardial infarction within 12 months of study entry"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 42,
                    "description": "Arrhythmias requiring continued treatment (controlled atrial fibrillation allowed)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 43,
                    "description": "QTcF interval > 460 msec (using Fridericia's formula)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 44,
                    "description": "Presence of active gastrointestinal disease or other condition that is expected to interfere significantly with the absorption, distribution, metabolism, or excretion of oral therapy (e.g. ulcerative disease, uncontrolled nausea, vomiting, diarrhea Grade \u2265 2, and malabsorption syndrome)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 45,
                    "description": "Inadequately controlled hypertension defined as systolic blood pressure >180 mmHg or diastolic blood pressure >100 mmHg (patients with values above these levels must have their blood pressure controlled prior to starting treatment)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 46,
                    "description": "Serious active infection at the time of treatment, or another serious underlying medical condition that would impair the ability of the patient to receive protocol treatment"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 47,
                    "description": "Other known active cancer(s) likely to require treatment in the next year that would impact the assessment of any study endpoints"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 48,
                    "description": "Psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "This study will evaluate the safety and tolerability of PMD-026 using an accelerated\r\n      titration design to define the MTD in metastatic breast cancer, followed by an expansion at\r\n      the RP2D in triple negative breast cancer. All patients will receive daily oral doses of\r\n      PMD-026 until either disease progression or unacceptable toxicity. Patients will have disease\r\n      assessments initially after 6 weeks of treatment, and every 9 weeks thereafter.\r\n\r\n      Patients enrolled to the Dose Escalation Phase must have histologically or cytologically\r\n      diagnosed metastatic breast cancer that has progressed on or after standard of care therapy.\r\n      Patients enrolled to the Dose Expansion Phase must have histologically or cytologically\r\n      diagnosed metastatic triple negative breast cancer from initial diagnosis (ER/PgR <1%, HER2\r\n      negative) that has progressed on or after standard of care therapy. All patients must provide\r\n      tumor tissue (archival preferred) prior to study entry.\r\n\r\n      A subset (N=12) of patients in Part 2 of the study will participate in a 1- week evaluation\r\n      of the effect of food on PMD-026 oral absorption.\r\n\r\n      PMD-026 is an oral, reversible small molecule inhibitor of RSK1-4 with high selectivity for\r\n      RSK2. High levels of RSK2 expression have been associated with worse overall survival in\r\n      breast cancer. Inhibiting RSK2 may inhibit growth of breast cancer.",
        "official_title": "Phase 1/1b Multicenter, Open-Label, First-in-Human Dose Escalation and Dose Expansion Study to Assess Safety and Tolerability of Orally Administered PMD-026 in Patients With Metastatic Breast Cancer With Expansion in Metastatic Triple Negative Breast Cancer",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "6 weeks",
                "name": "Duration of Response",
                "description": "The duration of response will be evaluated by disease assessments from time of first response (CR or PR) to time of disease progression.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "24 hours",
                "name": "Effect of food on PMD-026 PK",
                "description": "The effect of food on plasma concentration will be measured as part of pharmacokinetic (PK) testing.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "6 weeks",
                "name": "Efficacy in Patients",
                "description": "Anti-tumor activity (efficacy) will be assessed in all patients.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Through study completion, an average of 12 weeks",
                "name": "Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability)",
                "description": "Toxicities will be assessed in each patient by tracking the occurrence of graded Adverse Events (AEs). AEs will be graded according to the National Cancer Institute Common Terminology for Adverse Events (NCI CTCAE) v5.0.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 21 days",
                "name": "Maximum tolerated dose (MTD) of PMD-026",
                "description": "The MTD will be defined as the dose level at which no more than one of six patients experiences a dose limiting toxicity (DLT) after 21 days of treatment have occurred, with the next higher dose having at least 2 of 3 or 2 of 6 patients experiencing a DLT.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "24 hours",
                "name": "Plasma Concentration",
                "description": "The plasma concentration will be measured as part of pharmacokinetic (PK) testing.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "6 weeks",
                "name": "PMD-026 Activity in Tissue",
                "description": "PMD-026 activity will be evaluated in Lehmann subtypes in breast cancer tissue.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "2 weeks",
                "name": "PMD-026 pharmacodynamics and RSK signaling",
                "description": "PMD-026 pharmacodynamics will be evaluated on RSK signaling.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 14 months",
                "name": "Recommended Phase 2 Dose (RP2D) of PMD-026",
                "description": "The RP2D will be determined following the determination of the MTD and an overall assessment of safety as determined by the Safety Committee.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "6 weeks",
                "name": "RSK2 Expression",
                "description": "RSK2 expression will be evaluated in breast cancer tissue through immunohistochemistry (IHC).",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "12 weeks",
                "name": "RSK2 Expression and Response",
                "description": "The relationship between RSK2 expression and response will be evaluated following RSK2 IHC and disease assessments.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "6 weeks",
                "name": "Time to Response",
                "description": "The time to response will be evaluated by disease assessments.",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04115306",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C35681",
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C165233",
                    "C16612",
                    "C17756",
                    "C3367",
                    "C21295",
                    "C35681",
                    "C20719",
                    "C25870",
                    "C16152",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C17756",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Negative",
                    "PGR Negative",
                    "PR Negative",
                    "PR-"
                ],
                "nci_thesaurus_concept_id": "C15497",
                "name": "Progesterone Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20420",
                    "C35681",
                    "C36292",
                    "C20709",
                    "C20103",
                    "C16612",
                    "C94299",
                    "C77140",
                    "C21295",
                    "C54362",
                    "C16149",
                    "C165233",
                    "C3367",
                    "C28656"
                ],
                "parents": [
                    "C16149",
                    "C165233",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER-Negative PR-Negative ERBB2-Negative",
                    "ER-PR-HER2/neu-",
                    "ER-negative PR-negative HER2/neu-negative",
                    "ER/PR/HER2 Negative",
                    "ESR1/PGR/ERBB2 Negative Finding",
                    "Triple Negative Breast Cancer Finding",
                    "Triple Negative Breast Cancer Result",
                    "Triple-Negative Breast Cancer Result",
                    "triple-negative breast cancer"
                ],
                "nci_thesaurus_concept_id": "C71428",
                "name": "Triple-Negative Breast Cancer Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20103",
                    "C94299",
                    "C17756",
                    "C25871",
                    "C25872",
                    "C36292",
                    "C38349",
                    "C20709",
                    "C21281",
                    "C77140",
                    "C165233",
                    "C28656",
                    "C20420",
                    "C20719",
                    "C21295",
                    "C25870",
                    "C35681",
                    "C16612",
                    "C54362",
                    "C3367"
                ],
                "parents": [
                    "C165233",
                    "C17756",
                    "C28656",
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C21295",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C36292",
                    "C20103",
                    "C94299",
                    "C77140",
                    "C20709"
                ],
                "parents": [
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PgR Status",
                    "Progesterone Receptor"
                ],
                "nci_thesaurus_concept_id": "C16149",
                "name": "Progesterone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20420",
                    "C36292",
                    "C16612",
                    "C20709",
                    "C20103",
                    "C94299",
                    "C21295",
                    "C77140",
                    "C54362",
                    "C3367",
                    "C28656"
                ],
                "parents": [
                    "C28656",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Negative",
                    "ER Negative",
                    "ER-",
                    "ER-Alpha Negative",
                    "ERA Negative",
                    "ESR Negative",
                    "ESR1 Negative",
                    "ESRA Negative",
                    "ESTRR Negative",
                    "Estrogen Receptor 1 Negative",
                    "Estrogen Receptor Alpha Negative",
                    "NR3A1 Negative",
                    "Negative",
                    "Negative Estrogen Receptor",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Negative"
                ],
                "nci_thesaurus_concept_id": "C15493",
                "name": "Estrogen Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20420",
                    "C35681",
                    "C36292",
                    "C38349",
                    "C20709",
                    "C20103",
                    "C94299",
                    "C16612",
                    "C77140",
                    "C21295",
                    "C54362",
                    "C165233",
                    "C3367",
                    "C16150"
                ],
                "parents": [
                    "C16150",
                    "C165233",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2019-11-14",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IV Breast Carcinoma AJCC v8",
                    "Anatomic Stage IV Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139545",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IV Breast Cancer AJCC v8",
                    "Prognostic Stage IV Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139587",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139554"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C147965",
                "name": "Refractory Breast Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C8511"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C170728",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153348",
                "name": "Metastatic Triple-Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165698",
                    "C71732"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167076",
                "name": "Refractory Triple-Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165703",
                    "C71732"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Mammary Carcinoma",
                    "Carcinoma of Breast",
                    "Carcinoma of the Breast",
                    "Breast cancer, NOS",
                    "Cancer of Breast",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9335",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of Breast",
                    "Neoplasm of the Breast",
                    "Tumor of Breast",
                    "Tumor of the Breast",
                    "Breast Tumor"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C26709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2910",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165703",
                "name": "Refractory Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214",
                    "C147965",
                    "C159563"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Anatomic Stage"
                ],
                "nci_thesaurus_concept_id": "C139533",
                "name": "Breast Cancer by AJCC v8 Anatomic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165698",
                "name": "Metastatic Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4124",
                    "C5214",
                    "C153238"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C8511",
                "name": "Refractory Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C159563",
                "name": "Refractory Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C8511"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Triple-Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C71732",
                "name": "Triple-Negative Breast Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C53553"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139532",
                "name": "Breast Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C53553",
                "name": "Breast Carcinoma by Gene Expression Profile",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "resistant cancer",
                    "Refractory Cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C4124",
                "name": "Metastatic Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Cancer by AJCC v8 Prognostic Stage Group",
                    "Breast Carcinoma by AJCC v8 Prognostic Stage"
                ],
                "nci_thesaurus_concept_id": "C139554",
                "name": "Breast Cancer by AJCC v8 Prognostic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma of the Breast",
                    "Mammary adenocarcinoma",
                    "Adenocarcinoma of Breast"
                ],
                "nci_thesaurus_concept_id": "C5214",
                "name": "Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C2852"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "PMD-026-1-001",
        "active_sites_count": 5,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C61074",
                        "name": "Serine/Threonine Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Antineoplastic Drugs",
                            "Anti-Tumor Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs",
                            "Tumor-Specific Treatment Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Agent",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Protein Inhibitor",
                            "Antineoplastic Protein Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmacologic Agent",
                            "Drug",
                            "Agent",
                            "Pharmaceutical Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C166135",
                        "name": "RSK1-4 Inhibitor PMD-026",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129825",
                            "C61074"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "PMD-026",
                "description": "Oral PMD-026 (dose: 25 - 1000 mg), given daily until disease progression or unacceptable toxicity",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2020-01104",
        "why_study_stopped": null,
        "brief_summary": "The purpose of this study is to test the safety and tolerability of PMD-026 in patients with\r\n      metastatic breast cancer and triple negative breast cancer. PMD-026 is a targeted oral agent\r\n      designed to kill tumor cells in metastatic breast cancer and triple negative breast cancer.",
        "brief_title": "Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer",
        "status_history": [
            {
                "status_date": "2019-11-14T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 50,
        "_current_trial_status_sort_order": 0,
        "start_date": "2019-11-14",
        "record_verification_date": "2021-08-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Breast"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2022-02-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]